Evidence map›Paper›PMID 33035766›Full record

ReviewTuberculosis (Edinburgh, Scotland)2020

Modulation of the M. tuberculosis cell envelope between replicating and non-replicating persistent bacteria.

Haley Stokas, Heather L Rhodes, Georgiana E Purdy

Abstract readReview
In one paragraph

Review in Tuberculosis (Edinburgh, Scotland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Protein-Mediated Virulence in Mycobacterium tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  2. Article
  3. Drug-TolerantInternational journal of molecular sciences · 2023
    Article
  4. Frontiers in immunology · 2023
    Review
  5. Host- and Age-Dependent Transcriptional Changes inInternational journal of molecular sciences · 2022
    Article
  6. Review
  7. Evolution of Drug-ResistantFrontiers in microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haley StokasOregon Health & Science University, Department of Molecular Microbiology & Immunology, Portland, OR, 97239, United States.
Heather L RhodesOregon Health & Science University, Department of Molecular Microbiology & Immunology, Portland, OR, 97239, United States.
Georgiana E PurdyOregon Health & Science University, Department of Molecular Microbiology & Immunology, Portland, OR, 97239, United States. Electronic address: purdyg@ohsu.edu.

Funding

Metabolite modulation of Mtb regulators of cell wall biogenesisR01AI123148 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI PURDY, GEORGIANA E., YU, EDWARD W · 2017 to 2021
$2.4M
The role and fate of Mtb storage lipids LCTAG and MWER21AI144658 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI PURDY, GEORGIANA E. · 2020 to 2021
$438k
NIAID NIH HHS R01 AI123148NIAID NIH HHS R21 AI144658
6 · The paper itself

Abstract

The success of Mycobacterium tuberculosis as a human pathogen depends on the bacterium's ability to persist in a quiescent form in oxygen and nutrient-poor host environments. In vitro studies have demonstrated that these restricting environments induce a shift from bacterial replication to non-replicating persistence (NRP). Entry into NRP involves changes in bacterial metabolism and remodeling of the cell envelope. Findings consistent with the phenotypes observed in vitro have been observed in patient and animal model samples. This review focuses on the cell envelope differences seen between replicating and NRP M. tuberculosis and summarizes the ways in which serine/threonine protein kinases (STPKs) may mediate this process.

Indexed as

Gene Expression Regulation, BacterialAnimalsBacterial ProteinsCell DivisionCell MembraneCell WallHumansMycobacterium tuberculosisTuberculosisBacterial ProteinsDormancyLipidsMycobacterium tuberculosisMycolic acids

Identifiers

PMID33035766
PMCPMC7704923

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.